Soru

Zorluk: Çok zorPulmonary and Critical Care

Management is ongoing for a 7878-year-old man admitted 44 days ago with worsening dyspnea, orthopnea, and severe lower extremity swelling. He has a medical history significant for chronic obstructive pulmonary disease, hypertension, and ischemic cardiomyopathy with a left ventricular ejection fraction of 30%30\%. On admission, physical examination revealed elevated jugular venous pressure and bilateral crackles. Initial chest radiography demonstrated cardiomegaly and moderate bilateral pleural effusions.

He was immediately started on a continuous intravenous infusion of furosemide. Over the past 9696 hours, his weight has decreased by 77 kg (15.415.4 lb), and his oxygen requirements have normalized on room air. A follow-up chest radiograph obtained today demonstrates complete resolution of the left-sided effusion, but a persistent moderate right-sided pleural effusion. A diagnostic thoracentesis of the right pleural cavity yields 500500 mL of clear, yellow fluid. Concurrent laboratory studies are as follows:

StudySerumPleural Fluid
Total protein6.46.4 g/dL3.43.4 g/dL
Albumin3.93.9 g/dL2.02.0 g/dL
Lactate dehydrogenase (LDH)190190 U/L8585 U/L

(Reference range for serum LDH is 100−250100-250 U/L).

Pleural fluid analysis also shows a glucose level of 105105 mg/dL, a pH of 7.487.48, and a leukocyte count of 280280/mm³ (85%85\% mononuclear cells, 15%15\% neutrophils).

Which of the following is the most appropriate next step in the management of this patient's pleural fluid collection?

  1. Continue current diuretic therapyCevap
  2. B
    Administer empiric intravenous ceftriaxone and azithromycin
  3. C
    Insert a percutaneous thoracostomy tube
  4. D
    Perform a closed pleural biopsy
  5. E
    Initiate a therapeutic infusion of unfractionated heparin

Cevap

Continue current diuretic therapy
The correct management is to continue current diuretic therapy. This patient presents with an acute exacerbation of heart failure and is actively undergoing aggressive diuresis (7 kg weight loss in 4 days). His right-sided pleural fluid initially meets Light's criteria for an exudate because the pleural-to-serum protein ratio is 3.4/6.4=0.533.4 / 6.4 = 0.53 (which is >0.5> 0.5). However, in patients receiving potent diuretics, water is resorbed from the pleural space more rapidly than large molecules like protein and LDH. This concentrates the remaining fluid, converting a biochemical transudate into a 'pseudo-exudate'. When clinical suspicion for heart failure remains high but the fluid meets exudative criteria, the next step is to calculate the serum-to-pleural fluid albumin gradient (SPAG). The SPAG is calculated by subtracting the pleural fluid albumin from the serum albumin (3.9−2.0=1.93.9 - 2.0 = 1.9 g/dL). A gradient >1.2> 1.2 g/dL definitively confirms that the effusion is a transudate caused by hydrostatic pressure (heart failure), overriding Light's criteria. Because this is a transudate in a patient responding well to therapy, the most appropriate next step is to simply continue medical management with diuresis.

Adım Adım Çözüm

1
Calculate pleural fluid-to-serum ratios (Light's criteria) to initially classify the effusion.
The pleural-to-serum protein ratio is 3.4 / 6.4 = 0.53. Because this is > 0.5, the fluid meets one of Light's criteria and is initially classified as an exudate.
Light's criteria are the standard first step to differentiate transudative from exudative pleural effusions.
2
Recognize the clinical context of aggressive diuresis in a patient with heart failure.
The patient lost 7 kg over 4 days, leading to rapid fluid shifts out of the pleural space.
Diuresis clears water from the pleural space faster than it clears proteins and LDH, which can artificially concentrate these molecules and create a 'pseudo-exudate'.
3
Calculate the serum-to-pleural fluid albumin gradient (SPAG) to differentiate a true exudate from a diuretic-induced pseudo-exudate.
Serum albumin (3.9) - Pleural fluid albumin (2.0) = 1.9 g/dL.
When a clinically suspected transudate meets exudative criteria, a SPAG > 1.2 g/dL reliably overrides Light's criteria and confirms the fluid is actually a transudate.
4
Determine the appropriate management based on the true etiology of the effusion.
Since the fluid is a transudate secondary to volume overload from heart failure, the correct action is to continue medical management.
No invasive evaluation or targeted therapy for an exudate (like antibiotics or biopsy) is indicated for a heart failure transudate.

Anahtar Kavram

In patients with heart failure undergoing aggressive diuresis, pleural fluid may artificially concentrate and falsely meet Light's criteria for an exudate (pseudo-exudate); a serum-to-pleural fluid albumin gradient > 1.2 g/dL overrides Light's criteria and confirms the fluid is a transudate.
Bu soruyu puanla